MARIA RODRIGUEZ-BARRADAS to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications MARIA RODRIGUEZ-BARRADAS has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.400
-
Pitavastatin Is Well-Tolerated With no Detrimental Effects on Physical Function. Clin Infect Dis. 2025 Feb 24; 80(2):425-433.
Score: 0.147
-
Statin exposure and risk of cancer in people with and without HIV infection. AIDS. 2021 02 02; 35(2):325-334.
Score: 0.111
-
Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection Status. Clin Infect Dis. 2017 Oct 16; 65(9):1542-1550.
Score: 0.088
-
Lipid lowering effects of statins and fibrates in the management of HIV dyslipidemias associated with antiretroviral therapy in HIV clinical practice. J Infect. 2004 Nov; 49(4):283-90.
Score: 0.036
-
HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ function. Curr HIV Res. 2014; 12(1):50-9.
Score: 0.017